These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipopolysaccharide stimulation test on cultured PBMCs assists the discrimination of cryopyrin-associated periodic syndrome from systemic juvenile idiopathic arthritis. Wu CY, Fan WL, Chiu YM, Yang HY, Lee WI, Huang JL. Sci Rep; 2021 Jun 07; 11(1):11903. PubMed ID: 34099791 [Abstract] [Full Text] [Related]
3. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, Caiello I, Davì S, Schulert G, Ravelli A, Grom AA, de Min C, De Benedetti F. Ann Rheum Dis; 2017 Jan 07; 76(1):166-172. PubMed ID: 27296321 [Abstract] [Full Text] [Related]
4. Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis. Schulert GS, Zhang M, Husami A, Fall N, Brunner H, Zhang K, Cron RQ, Grom AA. Arthritis Rheumatol; 2018 Jun 07; 70(6):963-970. PubMed ID: 29409136 [Abstract] [Full Text] [Related]
5. Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome. Schulert GS, Pickering AV, Do T, Dhakal S, Fall N, Schnell D, Medvedovic M, Salomonis N, Thornton S, Grom AA. Ann Rheum Dis; 2021 May 07; 80(5):617-625. PubMed ID: 33277241 [Abstract] [Full Text] [Related]
6. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ. Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, Bader-Meunier B, Westhovens R, Van den Eynde BJ, Orabona C, Fallarino F, De Somer L, Tousseyn T, Quartier P, Wouters C, Matthys P. Rheumatology (Oxford); 2015 Aug 07; 54(8):1507-17. PubMed ID: 25767156 [Abstract] [Full Text] [Related]
7. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Budai MM, Varga A, Milesz S, Tőzsér J, Benkő S. Mol Immunol; 2013 Dec 07; 56(4):471-9. PubMed ID: 23911403 [Abstract] [Full Text] [Related]
8. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA. Ann Rheum Dis; 2020 Feb 07; 79(2):225-231. PubMed ID: 31707357 [Abstract] [Full Text] [Related]
9. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line. Luo M, Hu L, Li D, Wang Y, He Y, Zhu L, Ren W. Mol Immunol; 2017 Oct 07; 90():1-10. PubMed ID: 28654770 [Abstract] [Full Text] [Related]
10. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. Yu X, Lan P, Hou X, Han Q, Lu N, Li T, Jiao C, Zhang J, Zhang C, Tian Z. J Hepatol; 2017 Apr 07; 66(4):693-702. PubMed ID: 28027970 [Abstract] [Full Text] [Related]
11. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Kaufman KM, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich AH, Fall N, Harley JB, Nirmala NR, Grom AA. Arthritis Rheumatol; 2014 Dec 07; 66(12):3486-95. PubMed ID: 25047945 [Abstract] [Full Text] [Related]
12. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Weiss ES, Girard-Guyonvarc'h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, Schiffrin EJ, Foell D, Grom AA, Ammann S, Ehl S, Hoshino T, Goldbach-Mansky R, Gabay C, Canna SW. Blood; 2018 Mar 29; 131(13):1442-1455. PubMed ID: 29326099 [Abstract] [Full Text] [Related]
13. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome. Yasin S, Fall N, Brown RA, Henderlight M, Canna SW, Girard-Guyonvarc'h C, Gabay C, Grom AA, Schulert GS. Rheumatology (Oxford); 2020 Feb 01; 59(2):361-366. PubMed ID: 31326996 [Abstract] [Full Text] [Related]
14. Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts. Zhang A, Wang P, Ma X, Yin X, Li J, Wang H, Jiang W, Jia Q, Ni L. Mol Immunol; 2015 Aug 01; 66(2):253-62. PubMed ID: 25863775 [Abstract] [Full Text] [Related]
15. The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome. Gleeson TA, Kaiser C, Lawrence CB, Brough D, Allan SM, Green JP. Dis Model Mech; 2024 Jul 01; 17(7):. PubMed ID: 38775430 [Abstract] [Full Text] [Related]
16. Procyanidin B2 inhibits inflammasome-mediated IL-1β production in lipopolysaccharide-stimulated macrophages. Martinez-Micaelo N, González-Abuín N, Pinent M, Ardévol A, Blay M. Mol Nutr Food Res; 2015 Feb 01; 59(2):262-9. PubMed ID: 25379992 [Abstract] [Full Text] [Related]
17. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome. Shao A, Wu H, Hong Y, Tu S, Sun X, Wu Q, Zhao Q, Zhang J, Sheng J. Mol Neurobiol; 2016 Jul 01; 53(5):3462-3476. PubMed ID: 26091790 [Abstract] [Full Text] [Related]
18. Paeonol reduces IL-β production by inhibiting the activation of nucleotide oligomerization domain-like receptor protein-3 inflammasome and nuclear factor-κB in macrophages. Chen G, Guo T, Yang L. Biochem Cell Biol; 2022 Feb 01; 100(1):28-36. PubMed ID: 34784237 [Abstract] [Full Text] [Related]
19. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid. Fang H, Shao S, Cao T, Lei J, Dang E, Zhang J, Wang G. J Dermatol Sci; 2016 Aug 01; 83(2):116-23. PubMed ID: 27174093 [Abstract] [Full Text] [Related]
20. Systemic juvenile idiopathic arthritis and macrophage activation syndrome: update on pathogenesis and treatment. Yasin S, Schulert GS. Curr Opin Rheumatol; 2018 Sep 01; 30(5):514-520. PubMed ID: 29870499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]